FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2140565961> ?p ?o ?g. }

• W2140565961 endingPage "392" @default.
• W2140565961 startingPage "385" @default.
• W2140565961 abstract "Background One goal of guideline-based asthma therapy is minimal use of short-acting β2 agonist (SABA) medications. Inner-city children with asthma are known to have high SABA use. Objective To examine factors associated with high SABA use in inner-city children with asthma. Methods One hundred inner-city children with persistent asthma were enrolled into a randomized controlled trial of an emergency department (ED) and home intervention. All children underwent serologic allergen specific IgE and salivary cotinine testing at the ED enrollment visit. Pharmacy records for the past 12 months were obtained. Number of SABA fills during the past 12 months was categorized into low- to moderate- vs high-use groups. SABA groups were compared by the number of symptom days and nights, allergen sensitization, and exposures. Regression models were used to predict high SABA use. Results Mean number of SABA fills over 12 months was 3.12. Unadjusted bivariate analysis showed that high SABA users were more than 5 times more likely to have an asthma hospitalization, almost 3 times more likely to have an asthma intensive care unit admission, and more than 3 times more likely to have prior specialty asthma care or positive cockroach sensitization than low to moderate SABA users. In the final regression model, for every additional inhaled corticosteroid fill, a child was 1.4 times more likely and a child with positive cockroach sensitization was almost 7 times more likely to have high SABA use when controlling for prior intensive care unit admission, receipt of specialty care, child age, and income. Conclusion Providers should closely monitor SABA and controller medication use, allergen sensitization, and exposures in children with persistent asthma. Trial registration ClinicalTrials.gov, identifier NCT01981564." @default.
• W2140565961 created "2016-06-24" @default.
• W2140565961 creator A5013997592 @default.
• W2140565961 creator A5026415610 @default.
• W2140565961 creator A5029843913 @default.
• W2140565961 creator A5030009504 @default.
• W2140565961 creator A5052302757 @default.
• W2140565961 creator A5073691060 @default.
• W2140565961 creator A5083591245 @default.
• W2140565961 creator A5088649018 @default.
• W2140565961 date "2015-05-01" @default.
• W2140565961 modified "2023-10-15" @default.
• W2140565961 title "Factors associated with high short-acting β2-agonist use in urban children with asthma" @default.
• W2140565961 cites W1563640302 @default.
• W2140565961 cites W1964570106 @default.
• W2140565961 cites W1970397466 @default.
• W2140565961 cites W1971307203 @default.
• W2140565961 cites W1973078774 @default.
• W2140565961 cites W1999044792 @default.
• W2140565961 cites W2001959854 @default.
• W2140565961 cites W2002225904 @default.
• W2140565961 cites W2003496739 @default.
• W2140565961 cites W2006475995 @default.
• W2140565961 cites W2011411454 @default.
• W2140565961 cites W2034847761 @default.
• W2140565961 cites W2035205434 @default.
• W2140565961 cites W2049632078 @default.
• W2140565961 cites W2051781957 @default.
• W2140565961 cites W2070197559 @default.
• W2140565961 cites W2078761628 @default.
• W2140565961 cites W2080143130 @default.
• W2140565961 cites W2084387088 @default.
• W2140565961 cites W2085265217 @default.
• W2140565961 cites W2106138332 @default.
• W2140565961 cites W2107458343 @default.
• W2140565961 cites W2112496633 @default.
• W2140565961 cites W2112544568 @default.
• W2140565961 cites W2119081139 @default.
• W2140565961 cites W2124097427 @default.
• W2140565961 cites W2132990782 @default.
• W2140565961 cites W2146742701 @default.
• W2140565961 cites W2147459392 @default.
• W2140565961 cites W2153402187 @default.
• W2140565961 cites W2161879794 @default.
• W2140565961 cites W2170710330 @default.
• W2140565961 cites W2187258174 @default.
• W2140565961 cites W2334097078 @default.
• W2140565961 cites W2436490697 @default.
• W2140565961 cites W4239218095 @default.
• W2140565961 doi "https://doi.org/10.1016/j.anai.2015.03.002" @default.
• W2140565961 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4426068" @default.
• W2140565961 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25840499" @default.
• W2140565961 hasPublicationYear "2015" @default.
• W2140565961 type Work @default.
• W2140565961 sameAs 2140565961 @default.
• W2140565961 citedByCount "20" @default.
• W2140565961 countsByYear W21405659612016 @default.
• W2140565961 countsByYear W21405659612017 @default.
• W2140565961 countsByYear W21405659612018 @default.
• W2140565961 countsByYear W21405659612019 @default.
• W2140565961 countsByYear W21405659612020 @default.
• W2140565961 countsByYear W21405659612021 @default.
• W2140565961 countsByYear W21405659612022 @default.
• W2140565961 countsByYear W21405659612023 @default.
• W2140565961 crossrefType "journal-article" @default.
• W2140565961 hasAuthorship W2140565961A5013997592 @default.
• W2140565961 hasAuthorship W2140565961A5026415610 @default.
• W2140565961 hasAuthorship W2140565961A5029843913 @default.
• W2140565961 hasAuthorship W2140565961A5030009504 @default.
• W2140565961 hasAuthorship W2140565961A5052302757 @default.
• W2140565961 hasAuthorship W2140565961A5073691060 @default.
• W2140565961 hasAuthorship W2140565961A5083591245 @default.
• W2140565961 hasAuthorship W2140565961A5088649018 @default.
• W2140565961 hasBestOaLocation W21405659612 @default.
• W2140565961 hasConcept C118552586 @default.
• W2140565961 hasConcept C126322002 @default.
• W2140565961 hasConcept C142724271 @default.
• W2140565961 hasConcept C187212893 @default.
• W2140565961 hasConcept C203014093 @default.
• W2140565961 hasConcept C207480886 @default.
• W2140565961 hasConcept C2776042228 @default.
• W2140565961 hasConcept C2776376669 @default.
• W2140565961 hasConcept C2780182762 @default.
• W2140565961 hasConcept C2780724011 @default.
• W2140565961 hasConcept C71924100 @default.
• W2140565961 hasConceptScore W2140565961C118552586 @default.
• W2140565961 hasConceptScore W2140565961C126322002 @default.
• W2140565961 hasConceptScore W2140565961C142724271 @default.
• W2140565961 hasConceptScore W2140565961C187212893 @default.
• W2140565961 hasConceptScore W2140565961C203014093 @default.
• W2140565961 hasConceptScore W2140565961C207480886 @default.
• W2140565961 hasConceptScore W2140565961C2776042228 @default.
• W2140565961 hasConceptScore W2140565961C2776376669 @default.
• W2140565961 hasConceptScore W2140565961C2780182762 @default.
• W2140565961 hasConceptScore W2140565961C2780724011 @default.
• W2140565961 hasConceptScore W2140565961C71924100 @default.
• W2140565961 hasIssue "5" @default.
• W2140565961 hasLocation W21405659611 @default.

• next